171 related articles for article (PubMed ID: 22294242)
1. Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells.
Yang B; Zhou H; Zhang XD; Liu Z; Fan FY; Sun YM
Mol Med Rep; 2012 Apr; 5(4):955-8. PubMed ID: 22294242
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
3. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
[TBL] [Abstract][Full Text] [Related]
4. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
[TBL] [Abstract][Full Text] [Related]
6. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
Shui C; Riggs BL; Khosla S
Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
[TBL] [Abstract][Full Text] [Related]
7. Gingipains promote RANKL-induced osteoclastogenesis through the enhancement of integrin β3 in RAW264.7 cells.
Mo W; Luo H; Wu J; Xu N; Zhang F; Qiu Q; Zhu W; Liang M
J Mol Histol; 2020 Apr; 51(2):147-159. PubMed ID: 32193744
[TBL] [Abstract][Full Text] [Related]
8. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
Wu SH; Zhong ZM; Chen JT
Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
10. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
[TBL] [Abstract][Full Text] [Related]
11. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
12. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Rahman MM; Bhattacharya A; Fernandes G
J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
[TBL] [Abstract][Full Text] [Related]
13. Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.
Liu Y; Shi Z; Silveira A; Liu J; Sawadogo M; Yang H; Feng X
J Biol Chem; 2003 Jun; 278(23):20603-11. PubMed ID: 12663664
[TBL] [Abstract][Full Text] [Related]
14. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
[TBL] [Abstract][Full Text] [Related]
15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
16. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation.
Shi Z; Silveira A; Patel P; Feng X
Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions.
Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
J Vet Sci; 2013; 14(4):405-12. PubMed ID: 23820214
[TBL] [Abstract][Full Text] [Related]
18. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
[TBL] [Abstract][Full Text] [Related]
19. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
